Regenxbio
RGNX
RGNX
183 hedge funds and large institutions have $927M invested in Regenxbio in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 65 increasing their positions, 59 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
10% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 59
4% more capital invested
Capital invested by funds: $894M → $927M (+$32.6M)
2.78% less ownership
Funds ownership: 83.9% → 81.12% (-2.8%)
Holders
183
Holding in Top 10
3
Calls
$2.8M
Puts
$2.27M
Top Buyers
| 1 | +$16.4M | |
| 2 | +$4.67M | |
| 3 | +$3.46M | |
| 4 |
MPAM
Monarch Partners Asset Management
Boston,
Massachusetts
|
+$2.63M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.49M |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$14.5M | |
| 3 | -$8.97M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$7.1M |
| 5 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$5.29M |